A 46-year-old woman with no cardiovascular history attends for an annual review. Her fasting lipid profile shows total cholesterol 7.2 mmol/L, LDL-C 5.3 mmol/L, HDL-C 1.0 mmol/L, triglycerides 1.6 mmol/L. She is a non-smoker, normotensive, and her calculated 10-year Framingham risk is 8%. According to the 2021 Canadian Cardiovascular Society dyslipidaemia guideline, what is the most appropriate management of her lipids?